Glioblastoma is an aggressive cancer with a median survival of 16 months. Thus, waiting for changes in tumor volume to determine prognosis is too slow to benefit the patient. In this study, we show that in vivo measurements of tumor metabolism with hyperpolarized magnetic resonance can detect changes more rapidly and reliably than conventional anatomic MRI throughout all stages of tumor progression. These data are supported through ex vivo metabolic profiling. Interpretation of these results demonstrate the value that hyperpolarized magnetic resonance can bring to the clinic by addressing specific challenges encountered throughout the the care of glioblastoma patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords